Tag: AVF
CX 2024 controversies programme to draw in global voices to ensure...
This year’s 2024 Chairing Cross (CX) Symposium (23–25 April, London, UK) will feature debates on the success of endovascular arteriovenous fistulas (AVFs) alongside patient...
VOLA II trial results to ‘change practice’ and ‘improve outcomes’
“We wanted to find a common language between interventional radiologists and nephrologists and we wanted to be sure that the angioplasty we have done...
Laminate Medical announces FDA clearance for VasQ AVF creation device
Laminate Medical Technologies has announced their flagship device, the VasQ External Vascular Support, has been cleared by the US Food and Drug Administration (FDA)...
Kate Steiner
From choosing her specialty to competing in dressage, interventional radiology (IR) lead at East and North Herts NHS Trust (Stevenage, UK) Kate Steiner speaks...
EVA meeting unveils new data and global perspectives to boost vascular...
The third EVA Meeting (23–24 June, Patras, Greece) sought to build on international collaboration and science, one of the stated aims of the meeting...
Simpler AVF maturation criteria lead to similar outcomes, say researchers
Maturation of an arteriovenous fistulas (AVF) fails to occur for 20–60% of patients who have one created for haemodialysis access, and there is a...
Renal Interventions’ top 10 stories of July
July was a month of acute kidney injury (AKI) updates and regulatory shifts, with empagliflozin winning European Medicines Agency approval and the US Food...
Volume flow measurement: Time for meaningful haemodynamic endpoints and variables?
Panos Kitrou is a consultant interventional radiologist at Patras University Hospital (Patras, Greece). He writes to set out "the need for a benchmark volume...
Enrolment completed in SAVE trial of Selution SLR for AVF treatment
MedAlliance has announced completion of patient enrolment in the SAVE clinical trial with the Selution Sustained Limus Release (SLR) 018 drug-eluting balloon (DEB) for...
Innovation in dialysis access: From vision to reality
Ali Kordzadeh is a consultant vascular and access surgeon at Mid and South Essex NHS Foundation Trust (UK) and a visiting professor at Anglia...
US survey shows lack of kidney patient awareness of minimally invasive...
A survey recently conducted by Medtronic and the US National Kidney Foundation (NKF) found that patients undergoing haemodialysis lack awareness about minimally invasive treatment...
“Essential” vascular access planning eased by new CKD progression tool
Existing guidelines’ recommendations for vascular access planning are mainly based on glomerular filtration rate (eGFR) changes. With “optimal timing for vascular access referral and...
WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study completes enrolment
Merit Medical has announced that is has completed enrolment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective,...
Pathfinder Medical and Imperial College London awarded Innovate UK Smart grant...
Pathfinder Medical has been awarded a Smart grant for a £1.1 million (US$1.4 million) project by Innovate UK, the UK's innovation agency. A press...
ESVS vessel diameter guidelines do not improve outcomes in new RCT
The European Society for Vascular Surgery (ESVS) guidelines on vascular access recommend minimal diameters of 2mm in the forearm and 3mm in the upper...
Data on new external support device suggest improved AVF outcomes and...
The Vascular Annual Meeting 2023 (14–17 June, National Harbor, USA) recently featured the presentation of new data on an external support device that may...
Brachiocephalic AVFs not superior to radiocephalic for tunnelled catheter patients
The results of a new study in the Annals of Vascular Surgery suggest that patients who also have a tunnelled dialysis catheter (TDC) do...
Cut follow-up time to improve AVF outcomes, study authors propose
An association has been found between early follow-up evaluation in the wake of arteriovenous fistula (AVF) creation procedures and reduced time to successful cannulation...
How effective is cost effectiveness for dialysis patients?
Attendees at the 2023 Charing Cross (CX) Symposium (25–27 April, London, UK) renal interventions session were treated to two presentations exploring the issue of...
Angioplasty-assisted maturation effective “even for small cephalic veins”
It has been suggested by some, such as Khalid Bashar (University Hospital Limerick, Limerick, Ireland) et al in the International Journal of Surgery in...
Renal Interventions’ top 10 stories of April 2023
April was a month of dialysis analysis and AVF updates, with end-stage renal disease (ESRD) also associated with adverse limb events in a new...
EndoAVF found usually less cost effective compared with sAVF
The Society for Clinical Vascular Surgery (SCVS) 50th Annual Symposium (25–29 March, Miami, USA) hosted a series of abstract presentations. Among them was one...
A call to arms: Reuse of mature venous conduits urged
“Recycle that vein!”—that was the appeal from the authors of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs) from patients...
Renal Interventions’ top 10 stories of March 2023
The month of March brought PAVE-2 updates, preservation debates and an assessment of the best options in marginal veins. A series of transplant updates,...
Covered stent improves AVF angioplasty outcomes in new trial
The AVeNEW study, a 24-month multicentre, international, prospective and randomised clinical trial has published results investigating percutaneous transluminal angioplasty (PTA) compared to PTA with...
Age ceiling for AVF “should be adjusted upwards”
Led by Hyangkyoung Kim (Ewha Womans University Medical Center, Seoul, South Korea) and featuring corresponding author Hoon Suk Park (The Catholic University of Korea...
PAVE-2, paclitaxel and sirolimus-coated balloons for AVF
Michael Robson and Narayan Karunanithy (King’s College London, London, UK) write to explore the range of options in drug-coated balloons (DCBs) for stenosis in...
Regenerative material found “safe and feasible” as haemodialysis access conduit
Autogenous fistulas offer advantages to haemodialysis patients, long-term survival and low rates of complication among them. But failed or slow maturation as well as...
AVGs “a better choice” than AVF when veins are marginal
A new study in the Journal of Vascular Access (JVA) has found that, while arteriovenous fistulas (AVFs) that do not require assistance to mature...
The 40-year lack of progress in haemodialysis access cannulation
Deborah J Brouwer-Maier is the vascular access marketing manager for Transonic (Ithaca, USA) and a haemodialysis nurse of almost 40 years. Exploring how her...
Early plan for “crash-landers” during tunnelled dialysis catheter placement crucial
The fourth annual Hamburg Dialysis Access Symposium (23–24 September, Hamburg, Germany) was recently organised and moderated by Robert Shahverdyan (Asklepios Clinic Barmbek, Hamburg, Germany),...
Cannulation issues compared for sAVF and endoAVF
A range of issues in cannulation in arteriovenous fistulas (AVF) have been laid out by Deborah Brouwer-Maier (Transonic Systems, Ithaca, USA) at VEITHsymposium (15–19...
UK analysis of fistula data finds potential seven-figure cost saving with...
A cost-modelling analysis in real-world comparator groups has illustrated a potentially significant financial benefit across the UK healthcare system to using the VasQ external...
Amplifi vein dilation system continues to show promise following latest first-in-human...
An update from the first-in-human study assessing the Amplifi vein dilation system (Artio Medical) was delivered by Surendra Shenoy (Washington University School of Medicine,...
KDOQI vascular access guidelines: Opportunity or concern for clinical research?
Earlier this year, in an interview with Renal Interventions, Scott Trerotola (Philadelphia, USA) remarked that “guidelines are a research workbook for the next generation”....
Arteriovenous graft use linked to venous thromboembolism risk in haemodialysis patients
In an observational cohort study of Medicare beneficiaries receiving haemodialysis, the use of an arteriovenous graft (AVG) compared with an arteriovenous fistula (AVF) was...
History warns us against “optimistic exuberance” in drug-coated balloon trials
The importance of assessing clinical trial data in an objective, balanced way has been borne out by recent history in the vascular surgery space,...
Intraoperative vascular mapping during haemodialysis access “should be incorporated into routine...
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin (Zucker School of Medicine at...
EVA meeting harnesses global, multidisciplinary experts and analysis to guide the...
Lively discussion on unmet needs and building on quiet developments in vascular access from leading surgeons, interventional radiologists, nephrologists and interventional nephrologists formed the...
Fistula ligation “should become a routine part of post-transplant care”
At this year’s Vascular Access for Hemodialysis Symposium (9–11 June, Charleston, USA), Alexander Toledo (University of North Carolina, Chapel Hill, USA) asserted the advantages...
Save Your Vein: Transforming venous preservation from hope into reality
Jeremy Crane (London, UK) discusses the topic of vein preservation—including its central importance to successful dialysis access creation, and practical measures for achieving it...
Sirogen™: A potential solution for improving arteriovenous fistula maturation
This advertorial is sponsored by Vascular Therapies
Arteriovenous fistula (AVF) maturation is a pivotal event in patients requiring haemodialysis. Maximising the number of fistulas that...
VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...
VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...
Pharmacological approaches to reducing arteriovenous fistula failure rates
Sanjay Misra (Rochester, USA) discusses the need for pharmacological approaches that can improve successful, long-term outcomes with arteriovenous fistulas (AVFs) and outlines a handful...
IN.PACT AV DCB “first and only” to show sustained and superior...
Medtronic has announced new randomised controlled data demonstrating the sustained and superior performance of the IN.PACT AV drug-coated balloon (DCB) compared to percutaneous transluminal...
The Alio SmartPatch™: Optimising dialysis patient monitoring with a wearable, non-invasive...
This advertorial is sponsored by Alio Medical
Owing to the various risk factors and potential complications faced by kidney disease patients undergoing dialysis treatment, new...
A raft of new directions for vascular access grafts
A departure from the “extreme mantra” of Fistula First unlocks the door to a new, dynamic vision that could swing the pendulum back to...
Largest real-world experience to date with VasQ device indicates long-term benefits...
The VasQ external support device (Laminate Medical) has demonstrated long-term benefits for radiocephalic (forearm) arteriovenous fistula (AVF) creation in a retrospective analysis of 150...
Humacyte announces publication of positive long-term follow-up data from phase 2...
Humacyte today announced that five-year data from a phase 2 clinical trial of patients receiving the investigational Human Acellular Vessel (HAV) for arteriovenous (AV)...
Largest patient series to date reinforces 4Fr WavelinQ system’s potential in...
A multicentre experience with the 4 French (4Fr) WavelinQ endoAVF system (BD) has found that the device is safe and effective, bolstering existing evidence...
Far infrared treatment of arteriovenous fistulas presents no acute haemodynamic changes
Far infrared radiation (FIR) has demonstrated no haemodynamic changes in the arteriovenous fistulas (AVFs) of haemodialysis patients, despite prior contradicting research. This is the...
Fistula trials among key areas set to benefit from MedAlliance acquiring...
Arteriovenous fistula (AVF) access is one of the key areas that is set to receive a boost following MedAlliance’s acquisition of its partner MDK...
IMPRESSION trial assessing MagicTouch AVF passes 50% enrolment
Concept Medical has shared the latest update from its IMPRESSION (Sirolimus-coated balloon angioplasty versus plain balloon angioplasty in the treatment of dialysis access dysfunction)...
Dialysis tech firm Pathfinder Medical secures £8.5 million
Pathfinder Medical, which has developed a proprietary technology to guide and accurately align catheters in endovascular procedures allowing clinicians to make connections across blood...
Experimental gel shows promise in aiding creation and development of arteriovenous...
Researchers from the University of Alabama at Birmingham (UAB; Birmingham, USA) and US firm Endomimetics are working to develop a long-sought-after, effective therapy that...
Combination therapies and dynamic AVFs among options that may solve fistula...
Arteriovenous fistulas (AVFs) are widely considered to be the holy grail in dialysis access, providing a more long-term solution than synthetic arteriovenous grafts (AVGs)...
Arrow recalls percutaneous thrombolytic device kits over risk of separation
Arrow International has recalled its Arrow-Trerotola over-the-wire 7Fr percutaneous thrombolytic device (PTD) kits, which are used to remove clots in adult patients who have...
Amplifi™ Vein Dilation System: A novel device under development designed to...
The Amplifi Vein Dilation System (Artio Medical) is an innovative device designed to dilate arm veins in preparation for arteriovenous fistula (AVF) surgery using...
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
Cannulation difficulties among biggest hurdles for device-created fistulas
Difficulties in cannulation are currently as pressing as any other challenge facing patients who undergo device-enabled arteriovenous fistula (AVF) creation for dialysis. This was...
“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...
VenoStent embarks on clinical trial to improve success rate of vascular...
VenoStent has announced successful enrolment in its initial feasibility clinical trial. The clinical trial is testing the safety and efficacy of its 3D-printed bioabsorbable...
Stable incidence and survival of AVFs seen in long-term study of...
Despite an older dialysis population, the proportion and survival of arteriovenous fistulas (AVFs) in Danish dialysis patients has not changed over a 39-year period....
IN.PACT AV DCB sustained “superior” effectiveness in subgroups with high reintervention...
Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB; Medtronic) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of...
Results from first-in-human study of Amplifi vein dilation system presented at...
Preliminary clinical results from a first-in-human study assessing the Amplifi vein dilation system (Artio Medical) were presented at this year’s Vascular InterVentional Advances conference (VIVA;...
Global FACT trial reports significant superficial arm vein dilation with FA-1...
Fist Assist Devices has just announced completion of the FACT trial, which evaluated the use of an intermittent pneumatic compression device, model FA-1, to...
Artio Medical completes enrolment of first-in-human trial investigating Amplifi vein dilation...
Artio Medical announced today it has completed enrolment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated...
Oversized balloon angioplasty technique safe and effective for AV fistula maturation
A retrospective analysis published in the Journal of Vascular Access (JVA) has shown that the oversized balloon angioplasty technique to assist arteriovenous (AV) fistula...
Multidisciplinary UK panel agrees roadmap and optimal interventions for symptomatic AVF...
Multidisciplinary panel of UK experts agrees on roadmap and optimal stepwise application of interventions for symptomatic AVF stenoses in haemodialysis patients. Ounali Jaffer (London,...
Does anaesthetic technique during AV fistula creation influence long-term successful outcomes?
The largest randomised controlled trial comparing long-term surgical outcomes between two different anaesthetic techniques, the ACCESs study, has just launched in the UK, to...
Fist Assist device for focal arm massage and increased vein circulation...
Fist Assist Devices has received US Food and Drug Administration (FDA) 510(k) clearance for use of the Fist Assist FA-1 device in the USA...
Concept Medical provides update on IMPRESSION trial to evaluate MagicTouch AVF
Concept Medical has provided an update on the progress of the IMPRESSION (sirolimus-coated balloon angioplasty versus plain balloon angioplasty in the treatment of dialysis access dysfunction)...
Arteriovenous fistulas contribute to higher survival of haemodialysis patients with COVID-19
A new study, published online in The Journal of Vascular Access (JVA), suggests that arteriovenous fistulas (AVFs) contribute to higher survival of haemodialysis patients...
Treating steal syndrome: Symptoms, flow rate and anastomosis location all key...
When it comes to treating steal syndrome, the extent to which the dialysis patient in question is displaying symptoms—as well as their flow rate...
Balloon angioplasty in critical time window central to endovascular success for...
Tackling the main culprit, stenosis in the arteriovenous anastomosis and outflow veins, with balloon angioplasty before it is “too late” can boost maturation rates...
XO Score scoring sheath platform gains CE mark to treat PAD...
Transit Scientific has announced CE mark clearance for its XO Score scoring sheath platform, allowing the technology to be used in the treatment of...
High-flow fistulas remain divisive, with uncertainty over reduction and outcomes
Discussions at this year’s Charing Cross (CX) 2021 Digital Edition (19–22 April, online) indicated that high-flow arteriovenous (AV) fistulas remain one of the more...
Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...
Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...
Ultrasound guidance shown to improve cannulation accuracy, particularly in harder-to-needle AV...
A small, randomised trial conducted in a UK dialysis unit has found that ultrasound guidance can improve cannulation accuracy—and this improvement may be most...